cmAngio® vs VitalConnect VitalPatch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by VitalConnect

AI Verdict

cmAngio® and VitalConnect VitalPatch are adjacent tools in cardiovascular AI, but serve distinct purposes. cmAngio® focuses on AI-powered detection of Breast Arterial Calcifications on mammograms for cardiovascular risk assessment, while VitalConnect VitalPatch provides real-time, continuous monitoring of vital signs and cardiac arrhythmias via a wearable biosensor for active patient management.

Choose cmAngio® if…

Choose cmAngio® if your primary objective is to leverage existing mammography data to assess a woman's cardiovascular health by detecting Breast Arterial Calcifications (BAC). This AI software is ideal for integrating cardiovascular risk insights into routine breast cancer screening workflows, providing valuable information without requiring additional radiation or patient procedures. It's best suited for healthcare providers aiming to enhance preventive care and identify at-risk individuals during their regular mammogram appointments.

View cmAngio® →

Choose VitalConnect VitalPatch if…

Choose VitalConnect VitalPatch if you need continuous, real-time monitoring of vital signs and cardiac arrhythmias for patients, whether in a hospital setting or through remote patient monitoring programs. This wearable biosensor is optimal for managing patients requiring ongoing assessment for acute changes, post-discharge monitoring, or long-term management of chronic cardiovascular conditions. It provides immediate access to critical patient data, enabling timely interventions and comprehensive remote care.

View VitalConnect VitalPatch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® VitalConnect VitalPatch
Pricing Paid, out-of-pocket Contact for pricing
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-based with wearable biosensor and patient-carried relay devices (VistaPhone/VistaTablet).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cmAngio®

cmAngio (Tool A) offers seamless integration into existing radiology workflows with quick installation and compatibility with any DICOM-compliant viewer, minimizing disruption to professional users. VitalConnect VitalPatch (Tool B), while designed for ease of use, involves patient adherence, device application, and management of relay devices, which introduces more variables and potential usability challenges for both patients and clinicians.

Clinical Value

VitalConnect VitalPatch

VitalConnect VitalPatch (Tool B) provides real-time, continuous monitoring of up to 11 vital signs and AI-driven detection of 21 cardiac arrhythmias, offering immediate and actionable clinical insights for a broad range of acute and chronic conditions. cmAngio (Tool A) offers valuable insights into cardiovascular risk through BAC detection on mammograms, but its impact is more focused on long-term risk assessment rather than immediate patient management.

Pricing & Value

VitalConnect VitalPatch

VitalConnect VitalPatch (Tool B) offers more transparency with a subscription-based model, monthly fees tied to clinical services, and widespread coverage by Medicare and private insurers, indicating a more established and predictable cost structure for healthcare organizations and patients. cmAngio (Tool A) requires contacting the vendor for pricing details, with only limited-time offers for no-cost implementation, which provides less long-term financial clarity.

Enterprise Readiness

VitalConnect VitalPatch

Both tools are FDA-cleared and HIPAA-compliant, demonstrating foundational enterprise readiness. However, VitalConnect VitalPatch (Tool B) explicitly mentions partnerships with healthcare organizations and wide coverage by Medicare and private insurers, suggesting a more mature and established pathway for enterprise adoption and reimbursement. While cmAngio (Tool A) boasts quick installation, the operational complexities of managing a remote patient monitoring program with established reimbursement pathways give Tool B an edge in overall enterprise readiness.

Innovation

VitalConnect VitalPatch

VitalConnect VitalPatch (Tool B) demonstrates broader technological innovation by combining a sophisticated wearable biosensor, real-time streaming of multiple vital signs, and AI-driven arrhythmia detection for continuous patient monitoring. cmAngio (Tool A) is innovative in applying AI to extract novel cardiovascular risk information from existing mammography data, but Tool B's integration of advanced hardware, real-time data, and AI for comprehensive physiological monitoring represents a more complex and expansive innovation in healthcare delivery.

Support & Docs

VitalConnect VitalPatch

VitalConnect VitalPatch (Tool B) provides clear evidence of comprehensive patient and technical support resources, including detailed Instructions for Use, Quick Start Guides, and direct contact information for technical support and billing. In contrast, the provided information for cmAngio (Tool A) only mentions an 'Operator's Manual' without further details on accessibility or dedicated support channels.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® VitalConnect VitalPatch
Name cmAngiou00ae VitalConnect VitalPatch
Company CureMetrix VitalConnect
Description FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. Wearable biosensor and cloud-based platform for real-time, continuous monitoring of vital signs and cardiac arrhythmias for healthcare professionals, enabling remote patient monitoring and in-hospital care.
Key Functionality AI-based detection of Breast Arterial Calcifications (BAC) on mammograms Real-time, continuous monitoring of vital signs and cardiac arrhythmias with a wearable biosensor
Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Critical Care, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and VitalConnect VitalPatch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health risk assessment for women undergoing mammography. VitalConnect VitalPatch is a wearable biosensor and cloud-based platform for real-time, continuous monitoring of vital signs and cardiac arrhythmias, primarily for remote patient monitoring and in-hospital care in cardiology, critical care, and emergency medicine.
cmAngiou00ae analyzes existing Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, requiring no additional radiation or procedures for the patient. VitalConnect VitalPatch uses a wearable biosensor applied to the patient's chest for continuous, real-time physiological data collection, which is then transmitted via patient-carried relay devices (VistaPhone/VistaTablet).
cmAngiou00ae utilizes AI for the detection and visualization of Breast Arterial Calcifications (BAC) on mammograms, and can provide a proprietary Bradley Score for coronary risk assessment. VitalConnect VitalPatch employs AI algorithms for the detection of 21 cardiac arrhythmias and streams up to 11 vital signs, including live ECG.
cmAngiou00ae provides valuable cardiovascular insights from an existing mammogram without requiring any additional patient procedures or radiation exposure. The VitalConnect VitalPatch is a lightweight, water-resistant (IPX7) wearable biosensor designed for 7-day (168-hour) continuous wear, offering patient comfort and minimal disruption to daily activities.

Backers

Who funded each tool's parent company.

cmAngio®

VitalConnect VitalPatch

AI Tool Finder
AI-powered search. Results may not be comprehensive.